Page 55 - MONOGRAFIA 25, de Esclerosis multiple

VITAMINA D Y OTROS FACTORES AMBIENTALES
02
18. Nielsen NM, Munger KL, Koch-Henriksen N, Hougaard DM, Magyari M, Jørgensen KT, et al. Neonatal vitamin D status and risk of multiple sclerosis: a population-based case-control study. Neurology. 2017;88:44-51.
19. Sintzel MB, Rametta M, Reder AT. Vitamin D and Multiple Sclerosis: a Comprehensive Review. Neurol Ther. 2017 Dec 14 [Epub ahead of print].
20. Derakhshandi H, Etemadifar M, Feizi A, Abtahi SH, Minagar A, Abtahi MA, et al. Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial. Acta Neurol Belg. 2013;113:257-63.
21. Mowry EM, Pelletier D, Gao Z, Howell MD, Zamvil SS, Waubant E. Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection. Eur J Neurol. 2016;23:327-32.
22. Muris AH, Smolders J, Rolf L, Klinkenberg LJ, van der Linden N, Meex S, et al. Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow- Up. PLoS One. 2016;11:e0156122.
23. University of California, San Francisco MS-EPIC Team: Cree BA, Gourraud PA, Oksenberg JR, Bevan C, et al. Long-term evolution of multiple sclerosis disability in the treatment era. Ann Neurol. 2016;80:499-510.
24. Rotstein DL, Healy BC, Malik MT, Carruthers RL, Musallam AJ, Kivisakk P, et al. Effect of vitamin D on MS activity by disease-modifying therapy class. Neurol Neuroimmunol Neuroinflamm. 2015;2:e167.
25. Laursen JH, Søndergaard HB, Sørensen PS, Sellebjerg F, Oturai AB. Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab. Mult Scler Relat Disord. 2016;10:169-73.
26. James E, Dobson R, Kuhle J, Baker D, Giovannoni G, Ramagopalan SV. The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis. Mult Scler. 2013;19:1571-9.
27. Sotirchos ES, Bhargava P, Eckstein C, Van Haren K, Baynes M, Ntranos A, et al. Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis. Neurology.
2016;86:382-90.
28. Miclea A, Miclea M, Pistor M, Hoepner A, Chan A, Hoepner R. Vitamin D supplementation
differentially affects seasonal multiple sclerosis disease activity. Brain Behav. 2017;7:e00761.
29. Varsavsky M, Rozas Moreno P, Becerra Fernández A, Luque Fernández I, Quesada Gómez JM, Ávila Rubio V, et al. Recommended vitamin D levels in the general population. Endocrinol Diabetes
Nutr. 2017;64 Suppl 1:7-14.
55